Status:
COMPLETED
Special Investigation (Long-term Investigation) in Patients With Crohn's Disease
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Conditions:
Crohn's Disease
Eligibility:
All Genders
Brief Summary
This study of Humira will be conducted to obtain information on the safety (especially profile of malignant tumors and serious infections) and effectiveness in patients with Crohn's disease who are re...
Eligibility Criteria
Inclusion
- Patients with Crohn's disease indicated for Humira treatment with the recommended dosage regimen
- Patients with no past- or present malignant tumors
- Patients who are not currently receiving Humira
Exclusion
- None.
Key Trial Info
Start Date :
December 16 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2018
Estimated Enrollment :
511 Patients enrolled
Trial Details
Trial ID
NCT01464333
Start Date
December 16 2011
End Date
March 31 2018
Last Update
May 20 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.